EQUITY RESEARCH MEMO

ForSight Robotics

Generated 6/11/2026

Executive Summary

Conviction (model self-assessment)75/100

ForSight Robotics is a privately held ophthalmic medical device company headquartered in Yokneam Illit, Israel, founded in 2020. The company has developed the JASPER™ Robotic Surgery Platform, an AI-driven, high-precision system designed to enhance cataract surgery and other ophthalmic procedures. JASPER combines micron-level robotic control, 3D intra-operative imaging, and real-time data analytics to improve surgeon performance and patient outcomes. With $125 million in total funding, the company is progressing through the platform development stage and targeting a significant market opportunity in the aging global population requiring cataract surgery.

Upcoming Catalysts (preview)

  • Q2 2027FDA 510(k) clearance for JASPER platform65% success
  • Q4 2026Pivotal clinical trial data readout70% success
  • Q3 2026Strategic partnership with a major ophthalmic company50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)